Validation of the Glasgow-Blatchford Bleeding Score for Adults with Upper Gastrointestinal Bleeding in Tunisia

What this Trial Is About

This research aims to validate the Glasgow-Blatchford Score GBS in adults presenting with non-traumatic upper gastrointestinal bleeding in Tunisia. The study addresses the challenge of routinely hospitalizing all patients for observation by evaluating whether GBS can accurately predict risks like rebleeding, the need for hemostatic treatment, complications, and mortality within 30 days. It is a multicenter, descriptive, and analytical observational study conducted in emergency departments. Adult patients aged 18 years and older with non-traumatic upper gastrointestinal bleeding will be included. Clinical and epidemiological information will be collected using a standard form that incorporates GBS criteria. Follow-up will occur 30 days after initial presentation to track adverse outcomes including rebleeding, need for intervention, complications, and death. The performance of the GBS will be assessed statistically for sensitivity, specificity, and predictive values. Participants will have their clinical data recorded at emergency department visits. A telephone follow-up at 30 days will gather information about any complications or mortality. Researchers will analyze the data to determine how well the GBS predicts outcomes in this population. The total duration of involvement per participant will be approximately 30 days, with confidentiality and informed consent ensured throughout the study.

External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian Population